| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 3 |
| 1 | LAMIVUDINE ORAL | 3 |
| 2 | ADEFOVIR DIPIVOXIL | 2 |
| 3 | DENOSUMAB | 1 |
| 4 | ELBASVIR AND GRAZOPREVIR | 1 |
| 5 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 |
| 6 | FLUTICASONE PROPIONATE AND SALMETEROL | 1 |
| 7 | PEGINTERFERON ALFA-2A | 1 |
| 8 | RIBAVIRIN | 1 |
| 9 | TOFACITINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 1 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 2 | LAMIVUDINE | 3 | 0.0001 |
| 3 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0000 |
| 4 | RIBAVIRIN | 1 | 0.0000 |
| 5 | DENOSUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 3 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 5 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |